Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing clinical study on milnacipran hydrochloride
jRCT1080220060Phase 4
- Sponsor
- Asahi Kasei Pharma
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of milnacipran in major depressive disorder (MDD), sponsored by Asahi Kasei Pharma.
02
Drugs
milnacipran
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on jRCT1080220060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080220060.